PTX3: A modulator of human coronary plaque vulnerability acting by macrophages type 2

International Journal of Cardiology

Volumn 176, Issue 3, 2014, Pages 710-717

  Pucci, S ^a   Fisco, T ^a   Zonetti, M J ^a   Bonanno, E ^a   Mazzarelli, P ^a   Mauriello, A ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Acute myocardial infarction; CXCR1 polymorphism; Macrophage type 2; Pentraxin; Th1 inflammatory infiltrate

Indexed keywords

C REACTIVE PROTEIN; PENTRAXIN 3; SERUM AMYLOID P;

AGED; ATHEROSCLEROTIC PLAQUE; BIOSYNTHESIS; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MACROPHAGE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; SERUM AMYLOID P-COMPONENT;

EID: 84908234062     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.07.109     Document Type: Article

References (39)

1. F. Crea, and G. Liuzzo Pathogenesis of acute coronary syndromes J Am Coll Cardiol 61 2013 1 11
2. P. Libby Inflammation in atherosclerosis Arterioscler Thromb Vasc Biol 32 2012 2045 2051
3. A. Mauriello, G. Sangiorgi, and S. Fratoni Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction J Am Coll Cardiol 45 2005 1585 1593
4. P. Libby Mechanisms of acute coronary syndromes and their implications for therapy N Engl J Med 368 2013 2004 2013
5. L.G. Spagnoli, E. Bonanno, G. Sangiorgi, and A. Mauriello Role of inflammation in atherosclerosis J Nucl Med 48 2007 1800 1815
6. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 2005 1685 1695
7. P. Fraticelli, M. Sironi, and G. Bianchi Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses J Clin Invest 107 2001 1173 1181
8. C. Murdoch, and A. Finn Chemokine receptors and their role in inflammation and infectious diseases Blood 95 2000 3032 3043
9. C. Murdoch, and A. Finn Chemokine receptors and their role in vascular biology J Vasc Res 37 2000 1 7
10. T. Kasama, K. Wakabayashi, M. Sato, R. Takahashi, and T. Isozaki Relevance of the CX3CL1/fractalkine-CX3CR1 pathway in vasculitis and vasculopathy Transl Res 155 2010 20 26
11. J.K. Damas, A. Boullier, and T. Waehre Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy Arterioscler Thromb Vasc Biol 25 2005 2567 2572
12. D. Moatti, S. Faure, and F. Fumeron Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease Blood 97 2001 1925 1928
13. S. Pucci, P. Mazzarelli, and M.J. Zonetti CX3CR1 receptor polymorphisms, Th1 cell recruitment, and acute myocardial infarction outcome: looking for a link Biomed Res Int 2013 2013 451349
14. A. Niessner, R. Marculescu, and A. Haschemi Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation Thromb Haemost 93 2005 949 954
15. M. Presta, M. Camozzi, G. Salvatori, and M. Rusnati Role of the soluble pattern recognition receptor PTX3 in vascular biology J Cell Mol Med 11 2007 723 738
16. A. Mantovani, C. Garlanda, and B. Bottazzi The long pentraxin PTX3 in vascular pathology Vascul Pharmacol 45 2006 326 330
17. P. Kunes, Z. Holubcova, M. Kolackova, and J. Krejsek Pentraxin 3(PTX 3): an endogenous modulator of the inflammatory response Mediators Inflamm 2012 2012 920517
18. F. Bonacina, A. Baragetti, A.L. Catapano, and G.D. Norata Long pentraxin 3: experimental and clinical relevance in cardiovascular diseases Mediators Inflamm 2013 2013 725102
19. K. Inoue, A. Sugiyama, and P.C. Reid Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris Arterioscler Thromb Vasc Biol 27 2007 161 167
20. R. Latini, A.P. Maggioni, and G. Peri Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction Circulation 110 2004 2349 2354
21. G. Peri, M. Introna, and D. Corradi PTX3, a prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans Circulation 102 2000 636 641
22. M. Salio, S. Chimenti, and N. De Angelis Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction Circulation 117 2008 1055 1064
23. R. Virmani, F.D. Kolodgie, A.P. Burke, A. Farb, and S.M. Schwartz Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions Arterioscler Thromb Vasc Biol 20 2000 1262 1275
24. A.P. Burke, A. Farb, and G.T. Malcom Coronary risk factors and plaque morphology in men with coronary disease who died suddenly N Engl J Med 336 1997 1276 1282
25. S. Morikawa, W. Takabe, and C. Mataki Global analysis of RNA expression profile in human vascular cells treated with statins J Atheroscler Thromb 11 2004 62 72
26. B. Bottazzi, A. Bastone, and A. Doni The long pentraxin PTX3 as a link among innate immunity, inflammation, and female fertility J Leukoc Biol 79 2006 909 912
27. Y. Matsuura, K. Hatakeyama, and T. Imamura Different distribution of pentraxin 3 and C-reactive protein in coronary atherosclerotic plaques J Atheroscler Thromb 19 2012 837 845
28. D.H. McDermott, A.M. Fong, and Q. Yang Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans J Clin Invest 111 2003 1241 1250
29. T. Soeki, T. Niki, and K. Kusunose Elevated concentrations of pentraxin 3 are associated with coronary plaque vulnerability J Cardiol 58 2011 151 157
30. M.S. Rolph, S. Zimmer, and B. Bottazzi Production of the long pentraxin PTX3 in advanced atherosclerotic plaques Arterioscler Thromb Vasc Biol 22 2002 e10 e14
31. C.L. Jackson, and M.A. Reidy Basic fibroblast growth factor: its role in the control of smooth muscle cell migration Am J Pathol 143 1993 1024 1031
32. M. Camozzi, S. Zacchigna, and M. Rusnati Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo Arterioscler Thromb Vasc Biol 25 2005 1837 1842
33. G.E. Peoples, S. Blotnick, and K. Takahashi T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role Proc Natl Acad Sci U S A 92 1995 6547 6551
34. B. Bottazzi, V. Vouret-Craviari, and A. Bastone Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component J Biol Chem 272 1997 32817 32823
35. K.J. Woollard, and F. Geissmann Monocytes in atherosclerosis: subsets and functions Nat Rev Cardiol 7 2010 77 86
36. A. Mantovani, C. Garlanda, and M. Locati Macrophage diversity and polarization in atherosclerosis: a question of balance Arterioscler Thromb Vasc Biol 29 2009 1419 1423
37. G. Liu, and H. Yang Modulation of macrophage activation and programming in immunity J Cell Physiol 228 2013 502 512
38. Y. Komohara, J. Hirahara, and T. Horikawa AM-3K, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype J Histochem Cytochem 54 2006 763 771
39. J.J. Boyle, H.A. Harrington, and E. Piper Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype Am J Pathol 174 2009 1097 1108